MOU with BIOnSYSTEMS

페이지 정보

본문

In January 2023, Phytomab signed an MOU for joint new drug development research with BIOnSYSTEMS, a Korean biopharmaceutical company.

댓글목록

등록된 댓글이 없습니다.